CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Samil Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Samil Pharmaceutical Co Ltd
155, Hyoryeong-ro, Seocho-gu
Phone: +82 25200300p:+82 25200300 SEOUL, 06666  South Korea Ticker: 000520000520
Business Summary
Samil Pharmaceutical Co Ltd is a Korean-based company primarily engaged in the manufacturing and sale of pharmaceuticals. The Company operates through two segments. The Pharmaceutical segment mainly manufactures gastrointestinal motility regulators, nutritional supplements, gastrointestinal treatments, antipyretic analgesics and anti-inflammatory drugs, liver disease treatments and antihistamines, and also sells products used for glaucoma, depression and dry eyes. The Other segment mainly provides related services and also provides rental services. The Company also engages in the development of new drugs for ophthalmic diseases, liver diseases and circulatory and musculoskeletal conditions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
6512 Operators of nonresidential buildings
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Seung BeomHuh 43 3/21/2025 3/22/2013
President, Director Yu SeokShin 51 3/21/2025 3/21/2025
Vice President, Director Bu HwanGoh 57 1/1/2011 3/21/2008
10 additional Officers and Directors records available in full report.

Business Names
Business Name
000520
Samil Pharmaceutical Co., Ltd
Samil Pharmaceutical Co., Ltd.

General Information
Number of Employees: 395 (As of 12/31/2014)
Outstanding Shares: 21,229,653 (As of 9/30/2025)
Shareholders: 12,788
Stock Exchange: KRX
Fax Number: +82 25880988


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 21, 2025